Dibrompropamidine

Jump to: navigation, search
This image is provided by the National Library of Medicine.

WikiDoc Resources for Dibrompropamidine

Articles

Most recent articles on Dibrompropamidine

Most cited articles on Dibrompropamidine

Review articles on Dibrompropamidine

Articles on Dibrompropamidine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dibrompropamidine

Images of Dibrompropamidine

Photos of Dibrompropamidine

Podcasts & MP3s on Dibrompropamidine

Videos on Dibrompropamidine

Evidence Based Medicine

Cochrane Collaboration on Dibrompropamidine

Bandolier on Dibrompropamidine

TRIP on Dibrompropamidine

Clinical Trials

Ongoing Trials on Dibrompropamidine at Clinical Trials.gov

Trial results on Dibrompropamidine

Clinical Trials on Dibrompropamidine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dibrompropamidine

NICE Guidance on Dibrompropamidine

NHS PRODIGY Guidance

FDA on Dibrompropamidine

CDC on Dibrompropamidine

Books

Books on Dibrompropamidine

News

Dibrompropamidine in the news

Be alerted to news on Dibrompropamidine

News trends on Dibrompropamidine

Commentary

Blogs on Dibrompropamidine

Definitions

Definitions of Dibrompropamidine

Patient Resources / Community

Patient resources on Dibrompropamidine

Discussion groups on Dibrompropamidine

Patient Handouts on Dibrompropamidine

Directions to Hospitals Treating Dibrompropamidine

Risk calculators and risk factors for Dibrompropamidine

Healthcare Provider Resources

Symptoms of Dibrompropamidine

Causes & Risk Factors for Dibrompropamidine

Diagnostic studies for Dibrompropamidine

Treatment of Dibrompropamidine

Continuing Medical Education (CME)

CME Programs on Dibrompropamidine

International

Dibrompropamidine en Espanol

Dibrompropamidine en Francais

Business

Dibrompropamidine in the Marketplace

Patents on Dibrompropamidine

Experimental / Informatics

List of terms related to Dibrompropamidine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Dibrompropamidine is an antiseptic and disinfectant. As dibrompropamidine isethionate, it is used in eyedrops and ointment for the treatment of minor eye and eyelid infections in adults and children. In the UK, such preparations are sold under the brand names Brolene (Aventis Pharma), Golden Eye (Typharm Ltd) and Brulidine (Manx Healthcare).

Characteristics

A white or almost white, crystalline powder; odourless or almost odourless.

Freely soluble in water ; soluble in glycerol ; sparingly soluble in ethanol (96%); practically insoluble in chloroform, in ether, in liquid paraffin and in fixed oils.

References


Linked-in.jpg